Indications
Salazine is indicated in: Rheumatoid arthritis and juvenile arthritis: For the treatment of patients with rheumatoid arthritis, and of paediatric patients with polyarticular-course juvenile rheumatoid arthritis, who have responded inadequately to salicylates or other non-steroidal anti-inflammatory drugs (NSAIDs). Ulcerative colitis and Crohn's disease: As an adjunct in the treatment of ulcerative colitis, alongside the usual supportive and dietary measures. Also for the treatment of active Crohn's disease, especially in patients with colonic involvement.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
The mode of action of Sulfasalazine is still under investigation, but may be related to the anti inflammatory and/or immunomodulatory properties that have been observed in animal and in vitro models, to its affinity for connective tissue, and/or to the relatively high concentration it reaches in serous fluids, the liver and intestinal walls, as demonstrated in autoradiographic studies in animals. In ulcerative colitis, clinical studies utilizing rectal administration of Sulfasalazine, Sulfapyridine and 5-Aminosalyclic Acid have indicated that the major therapeutic action may reside in the 5-Aminosalyclic Acid moiety. The relative contribution of the parent drug and the major metabolites in rheumatoid arthritis is unknown.
Pregnancy & Breastfeeding
Pregnancy category B. This drug should only be used during pregnancy if it is clearly needed. Caution should be exercised when giving sulfasalazine to a nursing mother.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.